M&A Deal Summary |
|
---|---|
Date | 2014-02-03 |
Target | PreCision Dermatology |
Sector | Medical Products |
Buyer(s) | Bausch Health |
Sellers(s) | Triax Pharmaceuticals |
Deal Type | Add-on Acquisition |
Deal Value | 475M USD |
Advisor(s) | J.P. Morgan Securities (Financial) Gunderson Dettmer (Legal) |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Company |
---|---|
Sector | Life Science |
Employees | 20,270 |
Revenue | 8.8B USD (2023) |
Bausch Health is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, neurology, and branded generics. Bausch Health is based in Laval, Quebec.
DEAL STATS | # |
---|---|
Overall | 26 of 35 |
Sector (Medical Products) | 4 of 6 |
Type (Add-on Acquisition) | 19 of 25 |
State (Rhode Island) | 1 of 1 |
Country (United States) | 14 of 22 |
Year (2014) | 1 of 2 |
Size (of disclosed) | 7 of 27 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2013-12-16 |
Solta Medical
Hayward, California, United States Solta Medical, Inc. is a designer, developer, manufacturer and marketer of medical devices for the non-invasive treatment of wrinkles. |
Buy | $250M |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2014-11-17 |
NicOx
Warren Township, New Jersey, United States NicOx, Inc. distributes nitric oxide (NO)-donating drug. |
Buy | $20M |
Category | Company |
---|---|
Founded | 2004 |
Sector | Healthcare Services |
Triax Pharmaceuticals, LLC a specialty pharmaceutical company, engages in the development, sale, and marketing of dermatological products in the United States.
DEAL STATS | # |
---|---|
Overall | 1 of 1 |
Sector (Medical Products) | 1 of 1 |
Type (Add-on Acquisition) | 1 of 1 |
State (Rhode Island) | 1 of 1 |
Country (United States) | 1 of 1 |
Year (2014) | 1 of 1 |
Size (of disclosed) | 1 of 1 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2012-05-01 |
PreCision Dermatology
Cumberland, Rhode Island, United States PreCision Dermatology, Inc. is a specialty pharmaceutical company developing, manufacturing and marketing prescription and consumer dermatology products. Our mission is to develop innovative skincare therapies with proven clinical performance that patients prefer and physicians are confident to prescribe. |
Buy | $85M |